4.29

0.23% -0.010

After Hours: 4.29

Insight Molecular Diagnostics Inc (IMDX)

Overview News Price History Discussions Forecast

Insight Molecular Diagnostics Inc stock is traded at $4.29, with a volume of 36,361. It is down -0.23% in the last 24 hours and down -8.72% over the past month. Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.

Previous Close:

$4.30

Open:

$4.27

24h Volume:

36,361

Relative Volume:

0.15

Market Cap:

$140.39M

Revenue:

$1.95M

Net Income/Loss:

$-47.84M

P/E Ratio:

-2.8924

EPS:

-1.4832

Net Cash Flow:

$-27.46M

1W Performance:

-0.23%

1M Performance:

-8.72%

6M Performance:

-28.62%

1Y Performance:

+72.98%

1-Day Range:

$4.23

$4.32

1-Week Range:

$4.20

$4.54

52-Week Range:

$2.33

$8.51

Insight Molecular Diagnostics Inc Stock (IMDX) Company Profile

Name

Insight Molecular Diagnostics Inc

Sector

Healthcare (1082)

Industry

Diagnostics & Research (50)

Phone

949-409-7600

Address

2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE

Employee

Twitter

Next Earnings Date

2026-08-10

Latest SEC Filings

IMDX's Discussions on Twitter

Compare IMDX vs TMO, DHR, NTRA, A, IQV

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IMDX Insight Molecular Diagnostics Inc	4.29	140.71M	1.95M	-47.84M	-27.46M	-1.4832
TMO Thermo Fisher Scientific Inc	630.70	232.03B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	215.68	151.78B	24.78B	3.68B	5.29B	5.1743
NTRA Natera Inc	338.70	46.82B	2.50B	-226.32M	71.51M	-1.6412
A Agilent Technologies Inc	157.69	44.14B	7.23B	1.41B	1.09B	4.979
IQV Iqvia Holdings Inc	262.38	42.15B	16.63B	1.39B	2.12B	8.0674

Insight Molecular Diagnostics Inc Stock (IMDX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-28-25	Initiated	Lake Street	Buy
May-24-22	Downgrade	Stephens	Overweight → Equal-Weight
Mar-14-22	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Jan-07-22	Initiated	Stephens	Overweight
Jan-06-22	Resumed	Piper Sandler	Overweight
Mar-17-21	Resumed	Needham	Buy
Jan-07-21	Upgrade	The Benchmark Company	Speculative Buy → Buy
Dec-16-20	Upgrade	Piper Sandler	Neutral → Overweight
Nov-30-20	Initiated	BTIG Research	Buy
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight
Jul-30-20	Reiterated	The Benchmark Company	Speculative Buy
Jul-01-20	Downgrade	Piper Sandler	Overweight → Neutral
Jun-30-20	Downgrade	Chardan Capital Markets	Buy → Neutral
Jun-02-20	Initiated	Needham	Buy
Feb-13-19	Initiated	Piper Jaffray	Overweight
Jan-29-19	Upgrade	Janney	Neutral → Buy
Dec-19-18	Resumed	Lake Street	Buy

View All

Insight Molecular Diagnostics Inc Stock (IMDX) Latest News

Aug 19, 2026

Insight (IMDX) Price: Adds 2.34% to Close at $4.38 in Latest Trading; Price Levels: the $4.16 to $4.60 Range Remains in Focus in the Current UpdateTriangle Correction - vinanet.vn

Aug 19, 2026

Insight (IMDX) Earnings Brief: The Bottom-Line Figure Outpaces Its Comparison in Latest Trading; Market Read: The Stock Gains 0.23% at the CloseEarnings Surprise Score - vinanet.vn

Aug 19, 2026

Aug 18, 2026

symbol__ Stock Quote Price and Forecast - CNN

Aug 18, 2026

Lake Street Maintains Insight Molecular Diagnostics(IMDX.US) With Buy Rating, Maintains Target Price $12 - Moomoo

Aug 18, 2026

IMDX Reiterated by Needham -- Price Target Maintained at $9.00 - GuruFocus

Aug 18, 2026

Needham Maintains Insight Molecular Diagnostics(IMDX.US) With Buy Rating, Maintains Target Price $9 - Moomoo

Aug 18, 2026

Aug 17, 2026

Insight Molecular Diagnostics (IMDX) Q2 2026 Earnings Call Transcript - The Globe and Mail

Aug 17, 2026

Insight Molecular Diagnostics advances heart tr... - Pluang

Aug 17, 2026

Aug 15, 2026